Compile Data Set for Download or QSAR
Report error Found 42 Enz. Inhib. hit(s) with all data for entry = 50019857
TargetReceptor tyrosine-protein kinase erbB-2(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208409((S)-1-((4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino...)
Affinity DataIC50: 16nMAssay Description:Inhibition of human HER2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetEpidermal growth factor receptor(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208409((S)-1-((4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino...)
Affinity DataIC50: 26nMAssay Description:Inhibition of human EGFRMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReceptor tyrosine-protein kinase erbB-2(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208401(5-((1,4-diazepan-1-yl)methyl)-N-(1-(3-fluorobenzyl...)
Affinity DataIC50: 27nMAssay Description:Inhibition of human HER2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetEpidermal growth factor receptor(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208401(5-((1,4-diazepan-1-yl)methyl)-N-(1-(3-fluorobenzyl...)
Affinity DataIC50: 33nMAssay Description:Inhibition of human EGFRMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReceptor tyrosine-protein kinase erbB-2(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208410(1-((4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)pyr...)
Affinity DataIC50: 39nMAssay Description:Inhibition of human HER2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetEpidermal growth factor receptor(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208412(2-((4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)pyr...)
Affinity DataIC50: 45nMAssay Description:Inhibition of human EGFRMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReceptor tyrosine-protein kinase erbB-2(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208412(2-((4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)pyr...)
Affinity DataIC50: 47nMAssay Description:Inhibition of human HER2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReceptor tyrosine-protein kinase erbB-2(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208402(1-((4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)pyr...)
Affinity DataIC50: 63nMAssay Description:Inhibition of human HER2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetEpidermal growth factor receptor(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208402(1-((4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)pyr...)
Affinity DataIC50: 68nMAssay Description:Inhibition of human EGFRMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReceptor tyrosine-protein kinase erbB-2(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208397(N-(1-(3-fluorobenzyl)-1H-indazol-5-yl)-5-((6-methy...)
Affinity DataIC50: 74nMAssay Description:Inhibition of human HER2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReceptor tyrosine-protein kinase erbB-2(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208416((R)-1-((4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino...)
Affinity DataIC50: 76nMAssay Description:Inhibition of human HER2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetEpidermal growth factor receptor(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50204124(N-(1-(3-fluorobenzyl)-1H-indazol-5-yl)-5-methylpyr...)
Affinity DataIC50: 81nMAssay Description:Inhibition of human EGFRMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReceptor tyrosine-protein kinase erbB-2(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208399(N-(1-(3-fluorobenzyl)-1H-indazol-5-yl)-5-(piperazi...)
Affinity DataIC50: 81nMAssay Description:Inhibition of human HER2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReceptor tyrosine-protein kinase erbB-2(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50204124(N-(1-(3-fluorobenzyl)-1H-indazol-5-yl)-5-methylpyr...)
Affinity DataIC50: 88nMAssay Description:Inhibition of human HER2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetEpidermal growth factor receptor(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208399(N-(1-(3-fluorobenzyl)-1H-indazol-5-yl)-5-(piperazi...)
Affinity DataIC50: 90nMAssay Description:Inhibition of human EGFRMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReceptor tyrosine-protein kinase erbB-2(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208403(1-((4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)pyr...)
Affinity DataIC50: 110nMAssay Description:Inhibition of human HER2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReceptor tyrosine-protein kinase erbB-2(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208413(2-(((4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)py...)
Affinity DataIC50: 110nMAssay Description:Inhibition of human HER2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetEpidermal growth factor receptor(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208413(2-(((4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)py...)
Affinity DataIC50: 110nMAssay Description:Inhibition of human EGFRMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReceptor tyrosine-protein kinase erbB-2(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208407(N-(1-(3-fluorobenzyl)-1H-indazol-5-yl)-5-((4-methy...)
Affinity DataIC50: 120nMAssay Description:Inhibition of human HER2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReceptor tyrosine-protein kinase erbB-2(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208398(N-(1-(3-fluorobenzyl)-1H-indazol-5-yl)-5-((4-methy...)
Affinity DataIC50: 120nMAssay Description:Inhibition of human HER2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReceptor tyrosine-protein kinase erbB-2(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208408(N-(1-(3-fluorobenzyl)-1H-indazol-5-yl)-5-((4-(meth...)
Affinity DataIC50: 120nMAssay Description:Inhibition of human HER2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetEpidermal growth factor receptor(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208398(N-(1-(3-fluorobenzyl)-1H-indazol-5-yl)-5-((4-methy...)
Affinity DataIC50: 130nMAssay Description:Inhibition of human EGFRMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetEpidermal growth factor receptor(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208397(N-(1-(3-fluorobenzyl)-1H-indazol-5-yl)-5-((6-methy...)
Affinity DataIC50: 130nMAssay Description:Inhibition of human EGFRMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetEpidermal growth factor receptor(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208406(1-((4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)pyr...)
Affinity DataIC50: 140nMAssay Description:Inhibition of human EGFRMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetEpidermal growth factor receptor(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208407(N-(1-(3-fluorobenzyl)-1H-indazol-5-yl)-5-((4-methy...)
Affinity DataIC50: 170nMAssay Description:Inhibition of human EGFRMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReceptor tyrosine-protein kinase erbB-2(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208414(N-(1-(3-fluorobenzyl)-1H-indazol-5-yl)-5-((6-metho...)
Affinity DataIC50: 170nMAssay Description:Inhibition of human HER2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetEpidermal growth factor receptor(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208414(N-(1-(3-fluorobenzyl)-1H-indazol-5-yl)-5-((6-metho...)
Affinity DataIC50: 190nMAssay Description:Inhibition of human EGFRMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReceptor tyrosine-protein kinase erbB-2(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208415(4-((4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)pyr...)
Affinity DataIC50: 200nMAssay Description:Inhibition of human HER2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetEpidermal growth factor receptor(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208416((R)-1-((4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino...)
Affinity DataIC50: 200nMAssay Description:Inhibition of human EGFRMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetEpidermal growth factor receptor(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208408(N-(1-(3-fluorobenzyl)-1H-indazol-5-yl)-5-((4-(meth...)
Affinity DataIC50: 210nMAssay Description:Inhibition of human EGFRMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetEpidermal growth factor receptor(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208403(1-((4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)pyr...)
Affinity DataIC50: 220nMAssay Description:Inhibition of human EGFRMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetEpidermal growth factor receptor(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208411(1-((4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)pyr...)
Affinity DataIC50: 240nMAssay Description:Inhibition of human EGFRMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReceptor tyrosine-protein kinase erbB-2(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208406(1-((4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)pyr...)
Affinity DataIC50: 310nMAssay Description:Inhibition of human HER2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetEpidermal growth factor receptor(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208415(4-((4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)pyr...)
Affinity DataIC50: 350nMAssay Description:Inhibition of human EGFRMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReceptor tyrosine-protein kinase erbB-2(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208405(N-(1-(3-fluorobenzyl)-1H-indazol-5-yl)-5-(pyrrolid...)
Affinity DataIC50: 360nMAssay Description:Inhibition of human HER2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetEpidermal growth factor receptor(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208405(N-(1-(3-fluorobenzyl)-1H-indazol-5-yl)-5-(pyrrolid...)
Affinity DataIC50: 500nMAssay Description:Inhibition of human EGFRMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReceptor tyrosine-protein kinase erbB-2(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208400(1-(4-((4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)...)
Affinity DataIC50: 610nMAssay Description:Inhibition of human HER2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetEpidermal growth factor receptor(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208400(1-(4-((4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)...)
Affinity DataIC50: 710nMAssay Description:Inhibition of human EGFRMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReceptor tyrosine-protein kinase erbB-2(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208411(1-((4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)pyr...)
Affinity DataIC50: 750nMAssay Description:Inhibition of human HER2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetEpidermal growth factor receptor(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208410(1-((4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)pyr...)
Affinity DataIC50: 780nMAssay Description:Inhibition of human EGFRMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetEpidermal growth factor receptor(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208404(methyl 1-((4-(1-(3-fluorobenzyl)-1H-indazol-5-ylam...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human EGFRMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetReceptor tyrosine-protein kinase erbB-2(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50208404(methyl 1-((4-(1-(3-fluorobenzyl)-1H-indazol-5-ylam...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human HER2More data for this Ligand-Target Pair
In DepthDetails Article
PubMed